Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit
April 15 2020 - 9:05AM
Guardion Health Sciences, Inc. (“Guardion” or the “Company”)
(Nasdaq: GHSI), a company (i) that has developed medical foods and
medical devices in the ocular health marketplace and (ii) that is
developing nutraceuticals that the Company believes will provide
health benefits to consumers, announced today that Michael Favish,
CEO of Guardion Health Sciences, will present at the April 2020
Virtual Investor Summit on Wednesday, April 22nd, 2020 at 1:30 PM
Eastern Time.
A live audio webcast of the presentation will be
available in the News and Events section of the Company’s website
(guardionhealth.com). Immediately following the presentation,
management will participate in an interactive Q&A session with
interested parties, allowing participants to type in questions and
receive live responses.
To schedule a one-on-one call with management,
please contact the conference at info@virtualinvestorsummit.com and
for more information, please visit www.virtualinvestorsummit.com.
About Virtual Investor Summit
The Virtual Investor Summit is an online
platform that offers both public and private companies, across
multiple industries the ability to stay active and engaged with the
investment community. Our inaugural summit on April 22-23, 2020
will feature company webcast presentations followed by a virtual,
interactive Q&A session, allowing participants to type in
questions and receive live responses. Interested participants also
have the ability to request one-on-one calls with a featured
company. For more information, please visit
virtualinvestorsummit.com.
About Guardion Health Sciences, Inc.
Guardion is a specialty health sciences company
(i) that has developed medical foods and medical devices in the
ocular health marketplace and (ii) that is developing
nutraceuticals that the Company believes will provide medicinal and
health benefits to consumers. Information and risk factors with
respect to Guardion and its business, including its ability to
successfully develop and commercialize its proprietary products and
technologies, may be obtained in the Company’s filings with the SEC
at www.sec.gov.
Forward-Looking Statement Disclaimer
With the exception of the historical information
contained in this news release, the matters described herein may
contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Statements
preceded by, followed by or that otherwise include the words
“believes,” “expects,” “anticipates,” “intends,” “projects,”
“estimates,” “plans” and similar expressions or future or
conditional verbs such as “will,” “should,” “would,” “may” and
“could” are generally forward-looking in nature and not historical
facts, although not all forward-looking statements include the
foregoing. These statements involve unknown risks and uncertainties
that may individually or materially impact the matters discussed
herein for a variety of reasons that are outside the control of the
Company, including, but not limited to, the Company’s ability to
raise sufficient financing to implement its business plan, the
impact of the coronavirus (COVID-19) on the Company’s business and
the economy in general, and the Company’s ability to successfully
develop and commercialize its proprietary products and
technologies. Readers are cautioned not to place undue reliance on
these forward- looking statements, as actual results could differ
materially from those described in the forward-looking statements
contained herein. Readers are urged to read the risk factors set
forth in the Company’s filings with the SEC, which are available at
the SEC’s website (www.sec.gov). The Company disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
Guardion Health Sciences, Inc.
15150 Avenue of Science, Suite 200 San Diego, CA 92128Phone:
(858) 605-9055Fax: (858) 630-5543www.guardionhealth.com
Investor Relations Contact:
Jenene Thomas JTC Team, LLCTelephone: (833)
475-8247E-Mail: jtc@jtcir.com
Porter, LeVay & Rose, Inc.
Michael PorterTelephone: (212) 564-4700
E-mail: mike@plrinvest.com
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Apr 2023 to Apr 2024